Martin N, Elias N, Younger-Lewis D, et al. - Given the reports suggesting significant increase in a woman’s risk of premature cardiovascular disease (CVD) in correlation with experiencing hypertensive disorders of pregnancy (HDP) (ie, preeclampsia, gestational hypertension) and gestational diabetes mellitus (GDM), researchers sought to determine if and how CardioPrevent PostPartum (CPPP) affects health outcomes in high-risk postpartum women. Fourteen hours of health counselling was provided over 1 year to patients with recent history (≤ 5 years) of a HDP and/or GDM who were referred to CPPP. Measurement of outcomes was done at baseline, 6, and 12 months. At the time of evaluation (June 2020), 104 and 75 had complete 6-month and 12-month data, respectively, among the 228 participants enrolled in CPPP. Per outcomes, CVD risk improved significantly during participation in CPPP among this high-risk population.